1. 2016
  2. Development and in vitro evaluation of a microbicide gel formulation for a novel non-nucleoside reverse transcriptase inhibitor belonging to the N-dihydro-alkyloxy-benzyl-oxopyrimidines (N-DABOs) family. / Tintori, Cristina; Brai, Annalaura; Dasso Lang, Maria Chiara; Deodato, Davide; Greco, Antonia Michela; Bizzarri, Bruno Mattia; Cascone, Lorena; Casian, Alexandru; Zamperini, Claudio; Dreassi, Elena; Crespan, Emmanuele; Maga, Giovanni; Vanham, Guido; Ceresola, Elisa Rita; Canducci, Filippo; Ariën, Kevin K; Botta, Maurizio.

    In: J Med Chem, Vol. 59, No. 6, 2016, p. 2747-2759.

    Research output: Contribution to journalA1: Web of Science-article

  3. Inhibition of HIV virus by neutralizing Vhh attached to dual functional liposomes encapsulating dapivirine. / Wang, Scarlet Xiaoyan; Michiels, Johan; Ariën, Kevin K; New, Roger; Vanham, Guido; Roitt, Ivan.

    In: Nanoscale Research Letters, Vol. 11, 2016, p. 350.

    Research output: Contribution to journalA1: Web of Science-article

  4. 2015
  5. A cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in Sub-Saharan African women with relevance to HIV risk and prevention. / Kyongo Karanja, Jordan; Crucitti, Tania; Menten, Joris; Hardy, Liselotte; Cools, Piet; Michiels, Johan; Delany-Moretlwe, Sinead; Mwaura, Mary; Ndayisaba, Gilles; Joseph, Sarah; Fichorova, Raina; van de Wijgert, Janneke; Vanham, Guido; Ariën, Kevin K; Jespers, Vicky.

    In: Clinical and Vaccine Immunology, Vol. 22, No. 5, 2015, p. 526-538.

    Research output: Contribution to journalA1: Web of Science-article

  6. 2014
  7. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1. / Grammen, Carolien; Ariën, Kevin; Venkatraj, Muthusamy; Joossens, Jurgen; Van der Veken, Pieter; Heeres, Jan; Lewi, Paul J; Haenen, Steven; Augustyns, Koen; Vanham, Guido; Augustijns, Patrick; Brouwers, Joachim.

    In: Antiviral Research, Vol. 101, 2014, p. 113-121.

    Research output: Contribution to journalA1: Web of Science-article

  8. Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques. / Moog, C; Dereuddre-Bosquet, N; Teillaud, J-L; Biedma, M E; Holl, V; Vanham, Guido; Heyndrickx, L; Van Dorsselaer, A; Katinger, D; Vcelar, B; Zolla-Pazner, S; Mangeot, I; Kelly, C; Shattock, R J; Le Grand, R.

    In: Mucosal Immunology, Vol. 7, No. 1, 2014, p. 46-56.

    Research output: Contribution to journalA1: Web of Science-article

  9. What is the significance of posttreatment control of HIV infection vis-à-vis functional cure? / Vanham, Guido; Buvé, Anne; Florence, Eric; Seguin-Devaux, Carole; Sáez-Cirión, Asier.

    In: AIDS, Vol. 28, No. 4, 2014, p. 603-605.

    Research output: Contribution to journalA1: Web of Science-article

  10. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds. / Venkatraj, Muthusamy; Ariën, Kevin; Heeres, Jan; Joossens, Jurgen; Dirié, Bertrand; Lyssens, Sophie; Michiels, Johan; Cos, Paul; Lewi, Paul J; Vanham, Guido; Maes, Louis; Van der Veken, Pieter; Augustyns, Koen.

    In: Bioorganic and Medicinal Chemistry, Vol. 22, No. 19, 2014, p. 5241-5248.

    Research output: Contribution to journalA1: Web of Science-article

  11. 2013
  12. Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission. / Ariën, K.K.; Venkatraj, M.; Michiels, J.; Joossens, J.; Vereecken, Katleen; Van der Veken, P.; Abdellati, S.; Cuylaerts, V.; Crucitti, T.; Heyndrickx, L.; Heeres, J.; Augustyns, K.; Lewi, P.J.; Vanham, G.

    In: Journal of Antimicrobial Chemotherapy, Vol. 68, No. 9, 2013, p. 2038-2047.

    Research output: Contribution to journalA1: Web of Science-article

  13. The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody. / Balla-Jhagjhoorsingh, S.; Corti, D.; Heyndrickx, L.; Willems, E.; Vereecken, Katleen; Davis, D.; Vanham, G.

    In: PLoS ONE, Vol. 8, No. 7, 2013, p. e68863.

    Research output: Contribution to journalA1: Web of Science-article

  14. In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine. / das Neves, J.; Araujo, F.; Andrade, F.; Michiels, J.; Ariën, K.K.; Vanham, G.; Amiji, M.; Bahia, M.F.; Sarmento, B.

    In: Molecular Pharmaceutics, Vol. 10, No. 7, 2013, p. 2793-2807.

    Research output: Contribution to journalA1: Web of Science-article

Previous 1 2 3 4 5 6 7 8 ...20 Next

ID: 4718